Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Olivier Zwaenepoel

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Add to list
- Conference Paper
- C3
Single domain antibodies to study orphan receptors and tackle their mutant counterpart with dominant-negative effect

Edith De Bruycker (UGent) , Olivier Zwaenepoel (UGent) , Frauke Coppieters (UGent) , Elfride De Baere (UGent) and Jan Gettemans (UGent)

(2023) Nuclear Receptor Research Network, 15th Meeting, Abstracts.
Add to list
- Journal Article
- A1
- open access
Triazolinedione protein modification : from an overlooked off-target effect to a tryptophan-based bioconjugation strategy

Klaas Decoene, Kamil Ünal (UGent) , An Staes (UGent) , Olivier Zwaenepoel (UGent) , Jan Gettemans (UGent) , Kris Gevaert (UGent) , Johan Winne (UGent) and Annemieke Madder (UGent)

(2022) CHEMICAL SCIENCE. 13(18). p.5390-5397
Add to list
- Journal Article
- A1
- open access
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells

Tijs Merckaert (UGent) , Olivier Zwaenepoel (UGent) , Kris Gevaert (UGent) and Jan Gettemans (UGent)

(2021) BIOMEDICINE & PHARMACOTHERAPY. 133.
Add to list
- Journal Article
- A1
- open access
Development and characterization of protein kinase B/AKT isoform-specific nanobodies

Tijs Merckaert (UGent) , Olivier Zwaenepoel (UGent) , Kris Gevaert (UGent) and Jan Gettemans (UGent)

(2020) PLOS ONE. 15(10).
Add to list
Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging

Tim Hebbrecht, Jing Liu, Olivier Zwaenepoel (UGent) , Gaelle Boddin (UGent) , Chloé Van Leene (UGent) , Klaas Decoene, Annemieke Madder (UGent) , Kevin Braeckmans (UGent) and Jan Gettemans (UGent)

(2020) NEW BIOTECHNOLOGY. 59. p.33-43
Add to list
- Journal Article
- A1
- open access
Nb-induced stabilisation of p53 in HPV-infected cells

Anneleen Steels, Laura Vannevel, Olivier Zwaenepoel (UGent) and Jan Gettemans (UGent)

(2019) SCIENTIFIC REPORTS. 9.
Add to list
PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration

Wojciech G. Lesniak, Chengyan Chu, Anna Jablonska, Babak Behnam Azad, Olivier Zwaenepoel (UGent) , Michal Zawadzki, Ala Lisok, Martin G. Pomper, Piotr Walczak, Jan Gettemans (UGent) , et al.

(2019) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 46(9). p.1940-1951
Add to list
Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies

Anneleen Steels, Adriaan Verhelle (UGent) , Olivier Zwaenepoel (UGent) and Jan Gettemans (UGent)

(2018) MABS. 10(7). p.1045-1059
Add to list
Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells

Laurence Bertier (UGent) , Tim Hebbrecht, Elien Mettepenningen, Natasja De Wit, Olivier Zwaenepoel (UGent) , Adriaan Verhelle (UGent) and Jan Gettemans (UGent)

(2018) BIOMEDICINE & PHARMACOTHERAPY. 102. p.230-241
Add to list
- Journal Article
- A1
- open access
VCA nanobodies target N-WASp to reduce invadopodium formation and functioning

Tim Hebbrecht, Isabel Van Audenhove (UGent) , Olivier Zwaenepoel (UGent) , Adriaan Verhelle (UGent) and Jan Gettemans (UGent)

(2017) PLOS ONE. 12(9).

1
2

Next →